nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphotericin B—Weight increased—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Amphotericin B—Pain—Mycophenolic acid—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Amphotericin B—Constipation—Mycophenolic acid—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Amphotericin B—Weight decreased—Prednisone—systemic scleroderma	0.000387	0.000387	CcSEcCtD
Amphotericin B—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Amphotericin B—Hyperglycaemia—Prednisone—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Amphotericin B—Cough—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Amphotericin B—Hypotension—Lisinopril—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Amphotericin B—Dizziness—Captopril—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Amphotericin B—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Amphotericin B—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Amphotericin B—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Amphotericin B—Urticaria—Leflunomide—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Amphotericin B—Body temperature increased—Leflunomide—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Amphotericin B—Abdominal pain—Leflunomide—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Amphotericin B—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000376	0.000376	CcSEcCtD
Amphotericin B—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Amphotericin B—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Amphotericin B—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Amphotericin B—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Amphotericin B—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Amphotericin B—Myocardial infarction—Prednisone—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Amphotericin B—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Amphotericin B—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Amphotericin B—Hypersensitivity—Azathioprine—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Amphotericin B—Insomnia—Lisinopril—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Amphotericin B—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Amphotericin B—Paraesthesia—Lisinopril—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Amphotericin B—Vomiting—Captopril—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Amphotericin B—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Amphotericin B—Dyspnoea—Lisinopril—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Amphotericin B—Rash—Captopril—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Amphotericin B—Dermatitis—Captopril—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Amphotericin B—Somnolence—Lisinopril—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Amphotericin B—Headache—Captopril—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Amphotericin B—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Amphotericin B—Dyspepsia—Lisinopril—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Amphotericin B—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Amphotericin B—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Amphotericin B—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Amphotericin B—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Amphotericin B—Asthma—Methotrexate—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Amphotericin B—Infection—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Amphotericin B—Decreased appetite—Lisinopril—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Amphotericin B—Eosinophilia—Methotrexate—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Amphotericin B—Shock—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Amphotericin B—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Amphotericin B—Hypersensitivity—Leflunomide—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Amphotericin B—Pancreatitis—Methotrexate—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Amphotericin B—Pain—Lisinopril—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Amphotericin B—Constipation—Lisinopril—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Amphotericin B—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Amphotericin B—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Amphotericin B—Bradycardia—Prednisone—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Amphotericin B—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Amphotericin B—Diarrhoea—Azathioprine—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Amphotericin B—Haemoglobin—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Amphotericin B—Nausea—Captopril—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Amphotericin B—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Amphotericin B—Haemorrhage—Prednisone—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Amphotericin B—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Amphotericin B—Asthenia—Leflunomide—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Amphotericin B—Hallucination—Prednisone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Amphotericin B—Feeling abnormal—Lisinopril—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Amphotericin B—Pruritus—Leflunomide—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Amphotericin B—Connective tissue disorder—Prednisone—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Amphotericin B—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Amphotericin B—Dysuria—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Amphotericin B—Dizziness—Azathioprine—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Amphotericin B—Asthenia—Mycophenolic acid—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Amphotericin B—Diarrhoea—Leflunomide—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Amphotericin B—Urticaria—Lisinopril—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Amphotericin B—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Amphotericin B—Abdominal pain—Lisinopril—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Amphotericin B—Body temperature increased—Lisinopril—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Amphotericin B—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Amphotericin B—Pruritus—Mycophenolic acid—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Amphotericin B—Vomiting—Azathioprine—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Amphotericin B—Pneumonia—Methotrexate—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Amphotericin B—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Amphotericin B—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Amphotericin B—Rash—Azathioprine—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Amphotericin B—Dermatitis—Azathioprine—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Amphotericin B—Flushing—Prednisone—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Amphotericin B—Headache—Azathioprine—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Amphotericin B—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Amphotericin B—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Amphotericin B—Dizziness—Leflunomide—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Amphotericin B—Renal failure—Methotrexate—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Amphotericin B—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Amphotericin B—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Amphotericin B—Stomatitis—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Amphotericin B—Angiopathy—Prednisone—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Amphotericin B—Conjunctivitis—Methotrexate—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Amphotericin B—Immune system disorder—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Amphotericin B—Pain—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Amphotericin B—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Amphotericin B—Arrhythmia—Prednisone—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Amphotericin B—Sweating—Methotrexate—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Amphotericin B—Haematuria—Methotrexate—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Amphotericin B—Vomiting—Leflunomide—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Amphotericin B—Alopecia—Prednisone—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Amphotericin B—Hypersensitivity—Lisinopril—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Amphotericin B—Dizziness—Mycophenolic acid—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Amphotericin B—Epistaxis—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Amphotericin B—Rash—Leflunomide—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Amphotericin B—Dermatitis—Leflunomide—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Amphotericin B—Nausea—Azathioprine—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Amphotericin B—Headache—Leflunomide—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Amphotericin B—Erythema—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Amphotericin B—Malnutrition—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Amphotericin B—Agranulocytosis—Methotrexate—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Amphotericin B—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Amphotericin B—Asthenia—Lisinopril—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Amphotericin B—Pruritus—Lisinopril—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Amphotericin B—Vomiting—Mycophenolic acid—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Amphotericin B—Haemoglobin—Methotrexate—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Amphotericin B—Rash—Mycophenolic acid—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Amphotericin B—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Amphotericin B—Haemorrhage—Methotrexate—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Amphotericin B—Hepatitis—Methotrexate—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Amphotericin B—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Amphotericin B—Headache—Mycophenolic acid—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Amphotericin B—Pharyngitis—Methotrexate—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Amphotericin B—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Amphotericin B—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Amphotericin B—Nausea—Leflunomide—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Amphotericin B—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Amphotericin B—Urethral disorder—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Amphotericin B—Diarrhoea—Lisinopril—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Amphotericin B—Ill-defined disorder—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Amphotericin B—Visual impairment—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Amphotericin B—Anaemia—Prednisone—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Amphotericin B—Agitation—Prednisone—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Amphotericin B—Angioedema—Prednisone—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Amphotericin B—Dizziness—Lisinopril—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Amphotericin B—Erythema multiforme—Methotrexate—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Amphotericin B—Nausea—Mycophenolic acid—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Amphotericin B—Malaise—Prednisone—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Amphotericin B—Vertigo—Prednisone—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Amphotericin B—Syncope—Prednisone—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Amphotericin B—Tinnitus—Methotrexate—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Amphotericin B—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000264	CcSEcCtD
Amphotericin B—Loss of consciousness—Prednisone—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Amphotericin B—Vomiting—Lisinopril—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Amphotericin B—Angiopathy—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Amphotericin B—Immune system disorder—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Amphotericin B—Rash—Lisinopril—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Amphotericin B—Convulsion—Prednisone—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Amphotericin B—Dermatitis—Lisinopril—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Amphotericin B—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Amphotericin B—Hypertension—Prednisone—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Amphotericin B—Chills—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Amphotericin B—Headache—Lisinopril—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Amphotericin B—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Amphotericin B—Arthralgia—Prednisone—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Amphotericin B—Myalgia—Prednisone—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Amphotericin B—Anxiety—Prednisone—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Amphotericin B—Alopecia—Methotrexate—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Amphotericin B—Discomfort—Prednisone—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Amphotericin B—Malnutrition—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Amphotericin B—Erythema—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Amphotericin B—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Amphotericin B—Nausea—Lisinopril—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Amphotericin B—Oedema—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Amphotericin B—Anaphylactic shock—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Amphotericin B—Infection—Prednisone—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Amphotericin B—Back pain—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Amphotericin B—Shock—Prednisone—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Amphotericin B—Tachycardia—Prednisone—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Amphotericin B—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Amphotericin B—Skin disorder—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Amphotericin B—Hyperhidrosis—Prednisone—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Amphotericin B—Anorexia—Prednisone—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Amphotericin B—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Amphotericin B—Anaemia—Methotrexate—systemic scleroderma	0.00023	0.00023	CcSEcCtD
Amphotericin B—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Amphotericin B—Rash—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Amphotericin B—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Amphotericin B—Headache—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Amphotericin B—Malaise—Methotrexate—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Amphotericin B—Vertigo—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Amphotericin B—Leukopenia—Methotrexate—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Amphotericin B—Insomnia—Prednisone—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Amphotericin B—Paraesthesia—Prednisone—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Amphotericin B—Cough—Methotrexate—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Amphotericin B—Convulsion—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Amphotericin B—Dyspepsia—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Amphotericin B—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Amphotericin B—Myalgia—Methotrexate—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Amphotericin B—Chest pain—Methotrexate—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Amphotericin B—Arthralgia—Methotrexate—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Amphotericin B—Decreased appetite—Prednisone—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Amphotericin B—Discomfort—Methotrexate—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Amphotericin B—Constipation—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Amphotericin B—Confusional state—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Amphotericin B—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Amphotericin B—Infection—Methotrexate—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Amphotericin B—Feeling abnormal—Prednisone—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Amphotericin B—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Amphotericin B—Skin disorder—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Amphotericin B—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Amphotericin B—Anorexia—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Amphotericin B—Urticaria—Prednisone—systemic scleroderma	0.000193	0.000193	CcSEcCtD
Amphotericin B—Abdominal pain—Prednisone—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Amphotericin B—Body temperature increased—Prednisone—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Amphotericin B—Hypotension—Methotrexate—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Amphotericin B—Insomnia—Methotrexate—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Amphotericin B—Paraesthesia—Methotrexate—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Amphotericin B—Dyspnoea—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Amphotericin B—Somnolence—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Amphotericin B—Hypersensitivity—Prednisone—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Amphotericin B—Dyspepsia—Methotrexate—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Amphotericin B—Decreased appetite—Methotrexate—systemic scleroderma	0.000177	0.000177	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Amphotericin B—Asthenia—Prednisone—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Amphotericin B—Pain—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Amphotericin B—Pruritus—Prednisone—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Amphotericin B—Feeling abnormal—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Amphotericin B—Diarrhoea—Prednisone—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Amphotericin B—Urticaria—Methotrexate—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Amphotericin B—Dizziness—Prednisone—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Amphotericin B—Abdominal pain—Methotrexate—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Amphotericin B—Body temperature increased—Methotrexate—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Amphotericin B—Vomiting—Prednisone—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Amphotericin B—Rash—Prednisone—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Amphotericin B—Dermatitis—Prednisone—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Amphotericin B—Headache—Prednisone—systemic scleroderma	0.000152	0.000152	CcSEcCtD
Amphotericin B—Hypersensitivity—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Amphotericin B—Asthenia—Methotrexate—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Amphotericin B—Nausea—Prednisone—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Amphotericin B—Pruritus—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Amphotericin B—Diarrhoea—Methotrexate—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Amphotericin B—Dizziness—Methotrexate—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Amphotericin B—Vomiting—Methotrexate—systemic scleroderma	0.000129	0.000129	CcSEcCtD
Amphotericin B—Rash—Methotrexate—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Amphotericin B—Dermatitis—Methotrexate—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Amphotericin B—Headache—Methotrexate—systemic scleroderma	0.000127	0.000127	CcSEcCtD
Amphotericin B—Nausea—Methotrexate—systemic scleroderma	0.000121	0.000121	CcSEcCtD
